相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Novel genetic associations with interferon in systemic lupus erythematosus identified by replication and fine-mapping of trait-stratified genome-wide screen
Yogita Ghodke-Puranik et al.
CYTOKINE (2020)
An Assessment of LRRK2 Serine 935 Phosphorylation in Human Peripheral Blood Mononuclear Cells in Idiopathic Parkinson?s Disease and G2019S LRRK2 Cohorts
Shalini Padmanabhan et al.
JOURNAL OF PARKINSONS DISEASE (2020)
LRRK2 Phosphorylation, More Than an Epiphenomenon
Antoine Marchand et al.
FRONTIERS IN NEUROSCIENCE (2020)
Accurate MS-based Rab10 Phosphorylation Stoichiometry Determination as Readout for LRRK2 Activity in Parkinson's Disease
Oezge Karayel et al.
MOLECULAR & CELLULAR PROTEOMICS (2020)
Elevated In Vitro Kinase Activity in Peripheral Blood Mononuclear Cells ofLeucine-RichRepeat Kinase 2G2019SCarriers: A NovelEnzyme-LinkedImmunosorbent Assay-Based Method
Katerina Melachroinou et al.
MOVEMENT DISORDERS (2020)
LRRK2 links genetic and sporadic Parkinson's disease
Jillian H. Kluss et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2019)
Parkinson's disease-associated mutations in the GTPase domain of LRRK2 impair its nucleotide-dependent conformational dynamics
Chun-Xiang Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
LRRK2 is involved in the pathogenesis of system lupus erythematosus through promoting pathogenic antibody production
Meiyu Zhang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Circuit Mechanisms of Parkinson's Disease
Matthew M. McGregor et al.
NEURON (2019)
RAB8, RAB10 and RILPL1 contribute to both LRRK2 kinase-mediated centrosomal cohesion and ciliogenesis deficits
Antonio Jesus Lara Ordonez et al.
HUMAN MOLECULAR GENETICS (2019)
PPM1H phosphatase counteracts LRRK2 signaling by selectively dephosphorylating Rab proteins
Kerryn Berndsen et al.
ELIFE (2019)
Leucine-rich repeat kinase 2 (LRRK2) inhibitors differentially modulate glutamate release and Serine935 LRRK2 phosphorylation in striatal and cerebrocortical synaptosomes
Daniela Mercatelli et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2019)
LRRK2 phosphorylates membrane-bound Rabs and is activated by GTP-bound Rab7L1 to promote recruitment to the trans-Golgi network
Zhiyong Liu et al.
HUMAN MOLECULAR GENETICS (2018)
Proteomic analysis reveals co-ordinated alterations in protein synthesis and degradation pathways in LRRK2 knockout mice
Laura Pellegrini et al.
HUMAN MOLECULAR GENETICS (2018)
Nigrostriatal pathology with reduced astrocytes in LRRK2 S910/S935 phosphorylation deficient knockin mice
Ye Zhao et al.
NEUROBIOLOGY OF DISEASE (2018)
LRRK2 and its substrate Rab GTPases are sequentially targeted onto stressed lysosomes and maintain their homeostasis
Tomoya Eguchi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
LRRK2 activation in idiopathic Parkinson's disease
Roberto Di Maio et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Leucine-rich repeat kinase 2 controls protein kinase A activation state through phosphodiesterase 4
Isabella Russo et al.
JOURNAL OF NEUROINFLAMMATION (2018)
A pathway for Parkinson's Disease LRRK2 kinase to block primary cilia and Sonic hedgehog signaling in the brain
Herschel S. Dhekne et al.
ELIFE (2018)
Interrogating Parkinson's disease LRRK2 kinase pathway activity by assessing Rab10 phosphorylation in human neutrophils
Ying Fan et al.
BIOCHEMICAL JOURNAL (2018)
Rab29 activation of the Parkinson's disease-associated LRRK2 kinase
Elena Purlyte et al.
EMBO JOURNAL (2018)
Phosphorylation of amyloid precursor protein by mutant LRRK2 promotes AICD activity and neurotoxicity in Parkinson's disease
Zhong-Can Chen et al.
SCIENCE SIGNALING (2017)
A homologue of the Parkinson's disease-associated protein LRRK2 undergoes a monomer-dimer transition during GTP turnover
Egon Deyaert et al.
NATURE COMMUNICATIONS (2017)
Autophagy-related gene LRRK2 is likely a susceptibility gene for systemic lupus erythematosus in northern Han Chinese
Yue-miao Zhang et al.
ONCOTARGET (2017)
Phosphorylation of amyloid precursor protein by mutant LRRK2 promotes AICD activity and neurotoxicity in Parkinson's disease
Zhong-Can Chen et al.
SCIENCE SIGNALING (2017)
PAK6 Phosphorylates 14-3-3γ to Regulate Steady State Phosphorylation of LRRK2
Laura Civiero et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2017)
Selective LRRK2 kinase inhibition reduces phosphorylation of endogenous Rab10 and Rab12 in human peripheral mononuclear blood cells
Kenneth Thirstrup et al.
SCIENTIFIC REPORTS (2017)
Phos-tag analysis of Rab10 phosphorylation by LRRK2: a powerful assay for assessing kinase function and inhibitors
Genta Ito et al.
BIOCHEMICAL JOURNAL (2016)
Altered Development of Synapse Structure and Function in Striatum Caused by Parkinson's Disease-Linked LRRK2-G2019S Mutation
Bridget A. Matikainen-Ankney et al.
JOURNAL OF NEUROSCIENCE (2016)
Purification and Characterization of Progenitor and Mature Human Astrocytes Reveals Transcriptional and Functional Differences with Mouse
Ye Zhang et al.
NEURON (2016)
Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases
Martin Steger et al.
ELIFE (2016)
LRRK2 Pathways Leading to Neurodegeneration
Mark R. Cookson
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2015)
Discovery of a Pyrrolopyrimidine (JH-II-127), a Highly Potent, Selective, and Brain Penetrant LRRK2 Inhibitor
John M. Hatcher et al.
ACS MEDICINAL CHEMISTRY LETTERS (2015)
MLi-2, a Potent, Selective, and Centrally Active Compound for Exploring the Therapeutic Potential and Safety of LRRK2 Kinase Inhibitions
Matthew J. Fell et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
Differential LRRK2 Expression in the Cortex, Striatum, and Substantia Nigra in Transgenic and Nontransgenic Rodents
Andrew B. West et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2014)
An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex
Ye Zhang et al.
JOURNAL OF NEUROSCIENCE (2014)
LRRK2 regulates synaptogenesis and dopamine receptor activation through modulation of PKA activity
Loukia Parisiadou et al.
NATURE NEUROSCIENCE (2014)
ASTROCYTE REACTIVITY AND REACTIVE ASTROGLIOSIS: COSTS AND BENEFITS
Milos Pekny et al.
PHYSIOLOGICAL REVIEWS (2014)
Identification of protein phosphatase 1 as a regulator of the LRRK2 phosphorylation cycle
Evy Lobbestael et al.
BIOCHEMICAL JOURNAL (2013)
LRRK2 expression is enriched in the striosomal compartment of mouse striatum
Wim Mandemakers et al.
NEUROBIOLOGY OF DISEASE (2012)
Ser1292 Autophosphorylation Is an Indicator of LRRK2 Kinase Activity and Contributes to the Cellular Effects of PD Mutations
Zejuan Sheng et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Age-dependent and cell-population-restricted LRRK2 expression in normal mouse spleen
Tatsunori Maekawa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser910/Ser935, disruption of 14-3-3 binding and altered cytoplasmic localization
Nicolas Dzamko et al.
BIOCHEMICAL JOURNAL (2010)
14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization
R. Jeremy Nichols et al.
BIOCHEMICAL JOURNAL (2010)
The G2019S pathogenic mutation disrupts sensitivity of leucine-rich repeat kinase 2 to manganese kinase inhibition
Jason P. Covy et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Enhanced Striatal Dopamine Transmission and Motor Performance with LRRK2 Overexpression in Mice Is Eliminated by Familial Parkinson's Disease Mutation G2019S
Xianting Li et al.
JOURNAL OF NEUROSCIENCE (2010)
Dynamic and redundant regulation of LRRK2 and LRRK1 expression
Saskia Biskup et al.
BMC NEUROSCIENCE (2007)
The R1441C mutation of LRRK2 disrupts GTP hydrolysis
Patrick A. Lewis et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Localization of LRRK2 to membranous and vesicular structures in mammalian brain
Saskia Biskup et al.
ANNALS OF NEUROLOGY (2006)
Kinase activity is required for the toxic effects of mutant LRRK2/dardarin
Elisa Greggio et al.
NEUROBIOLOGY OF DISEASE (2006)
Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology
A Zimprich et al.
NEURON (2004)